tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

BLU

GSK says Bellus deal to be adjusted earnings accretive from 2027
The FlyGSK says Bellus deal to be adjusted earnings accretive from 2027
2y ago
BLU
GSK
Is BLU a Buy, Before Earnings?
PremiumPre-Earnings
Is BLU a Buy, Before Earnings?
2y ago
BLU
Pliant Therapeutics pullback on ‘really strong data’ unjustified, says Piper
PremiumThe Fly
Pliant Therapeutics pullback on ‘really strong data’ unjustified, says Piper
2y ago
BLU
PLRX
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
2y ago
AMC
Bellus Health downgraded to Hold from Buy at Jefferies
PremiumThe Fly
Bellus Health downgraded to Hold from Buy at Jefferies
2y ago
BLU
Bellus Health management to meet with Piper Sandler
PremiumThe FlyBellus Health management to meet with Piper Sandler
2y ago
BLU
Bellus Health cut to Sector Perform at RBC Capital on GSK deal
Premium
The Fly
Bellus Health cut to Sector Perform at RBC Capital on GSK deal
2y ago
BLU
GSK
Bellus Health downgraded to Sector Perform from Outperform at RBC Capital
Premium
The Fly
Bellus Health downgraded to Sector Perform from Outperform at RBC Capital
2y ago
BLU
Bellus Health downgraded to In Line from Outperform at Evercore ISI
PremiumThe Fly
Bellus Health downgraded to In Line from Outperform at Evercore ISI
2y ago
BLU
GSK to acquire Bellus Health for $14.75 per share
PremiumThe Fly
GSK to acquire Bellus Health for $14.75 per share
2y ago
BLU
GSK
Bellus Health Surges after Acquisition by GSK for $2 Billion
PremiumMarket News
Bellus Health Surges after Acquisition by GSK for $2 Billion
2y ago
BLU
GSK
Bellus Health management to meet with Piper Sandler
PremiumThe Fly
Bellus Health management to meet with Piper Sandler
2y ago
BLU
Bellus Health announces results from camlipixant bioavailability study
PremiumThe FlyBellus Health announces results from camlipixant bioavailability study
2y ago
BLU
Bellus Health reports FY22 EPS (66c), consensus (70c)
Premium
The Fly
Bellus Health reports FY22 EPS (66c), consensus (70c)
2y ago
BLU
Bellus Health reports Q3 EPS (20c), consensus (17c)
Premium
The Fly
Bellus Health reports Q3 EPS (20c), consensus (17c)
2y ago
BLU
2 Monster Growth Stocks That Could Reach New Highs
PremiumStock Analysis & Ideas
2 Monster Growth Stocks That Could Reach New Highs
2y ago
BLU
COGT
BELLUS Shares Have More Room to Run, Says Analyst
PremiumStock Analysis & Ideas
BELLUS Shares Have More Room to Run, Says Analyst
3y ago
BLU
BELLUS Health: Drug Trial Results SOOTHE the Market
PremiumStock Analysis & Ideas
BELLUS Health: Drug Trial Results SOOTHE the Market
3y ago
BLU
2 “Strong Buy” Penny Stocks That Could Rally Over 100%
PremiumStock Analysis & Ideas
2 “Strong Buy” Penny Stocks That Could Rally Over 100%
4y ago
BLU
OBSV
Bellus Health Craters 72% On Chronic Cough Miss; Analyst Still Says Buy
PremiumMarket NewsBellus Health Craters 72% On Chronic Cough Miss; Analyst Still Says Buy
4y ago
BLU

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >